Robert W. Baird Forecasts Strong Price Appreciation for Xylem (NYSE:XYL) Stock

Xylem (NYSE:XYL) had its price target increased by equities research analysts at Robert W. Baird from $163.00 to $165.00 in a report released on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the industrial products company’s stock. Robert W. Baird’s target price would indicate a potential upside of 32.13% from the company’s previous close.

Other equities analysts also recently issued research reports about the stock. Jefferies Financial Group raised shares of Xylem from a “hold” rating to a “buy” rating and raised their target price for the company from $130.00 to $140.00 in a research note on Thursday, June 25th. Weiss Ratings cut Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. CLSA raised shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. Stifel Nicolaus reduced their price target on shares of Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a research report on Monday, July 20th. Finally, UBS Group upped their price target on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Nine investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $153.85.

Xylem Stock Up 3.9%

Shares of NYSE:XYL opened at $124.87 on Wednesday. The stock has a 50 day moving average price of $114.64 and a 200-day moving average price of $122.45. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The firm has a market capitalization of $29.68 billion, a P/E ratio of 31.06, a P/E/G ratio of 1.71 and a beta of 1.03. Xylem has a 52-week low of $105.29 and a 52-week high of $154.27.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.12. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.34 billion during the quarter, compared to analyst estimates of $2.34 billion. During the same period last year, the business earned $1.26 EPS. Xylem’s quarterly revenue was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, equities research analysts anticipate that Xylem will post 5.52 EPS for the current fiscal year.

Insider Buying and Selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jerome A. Peribere acquired 1,210 shares of the firm’s stock in a transaction dated Monday, May 4th. The shares were purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.32% of the company’s stock.

Institutional Investors Weigh In On Xylem

A number of institutional investors and hedge funds have recently bought and sold shares of XYL. Commonwealth Retirement Investments LLC purchased a new stake in shares of Xylem during the fourth quarter worth about $27,000. Wexford Capital LP bought a new position in Xylem in the 3rd quarter worth approximately $27,000. Global Assets Advisory LLC purchased a new stake in Xylem during the 1st quarter valued at approximately $40,000. FWL Investment Management LLC purchased a new stake in Xylem during the 2nd quarter valued at approximately $43,000. Finally, Entrust Financial LLC bought a new stake in shares of Xylem during the fourth quarter valued at approximately $45,000. 87.96% of the stock is owned by institutional investors.

More Xylem News

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Quarterly earnings beat expectations: Xylem reported adjusted EPS of $1.46, above the $1.34 consensus and up from $1.26 a year earlier. Revenue was $2.34 billion, roughly in line with estimates and up about 1.5% year over year. Reuters article
• Positive Sentiment: Higher full-year guidance: Management raised 2026 adjusted EPS guidance to $5.55-$5.70 from $5.35-$5.60, while maintaining revenue guidance of approximately $9.2 billion. The increase was above the analyst consensus cited in the reports, improving expectations for future profitability. Zacks earnings article
• Positive Sentiment: Margins and orders strengthened: Adjusted EBITDA margin expanded 150 basis points to 23.3%, supported by productivity savings, pricing, and favorable mix. Orders surged 42% reported, or 41% organically, signaling strong demand momentum. Quiver Quantitative results article
• Positive Sentiment: AI-related demand is a growth catalyst: Xylem said data centers and broader AI infrastructure are increasing water-treatment and management spending across semiconductors, power generation, mining, food and beverage, and life sciences. William Blair reaffirmed a Buy rating, citing water-infrastructure growth and data-center demand. TipRanks analyst article
• Neutral Sentiment: At a reported P/E of approximately 31, XYL is valued at a premium, making sustained earnings growth and execution important for further gains. Analyst price targets remain generally above the current share price, but institutional ownership changes were mixed.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.